274 related articles for article (PubMed ID: 27708348)
1. A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP1
Fonseca JA; Cabrera-Mora M; Singh B; Oliveira-Ferreira J; da Costa Lima-Junior J; Calvo-Calle JM; Lozano JM; Moreno A
Sci Rep; 2016 Oct; 6():34527. PubMed ID: 27708348
[TBL] [Abstract][Full Text] [Related]
2. Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.
Cabrera-Mora M; Fonseca JA; Singh B; Oliveira-Ferreira J; Lima-Junior Jda C; Calvo-Calle JM; Moreno A
Infect Immun; 2015 Sep; 83(9):3749-61. PubMed ID: 26169267
[TBL] [Abstract][Full Text] [Related]
3. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1
Rocha MV; Françoso KS; Lima LC; Camargo TM; Machado RLD; Costa FTM; Rénia L; Nosten F; Russell B; Rodrigues MM; Soares IS
Vaccine; 2017 Apr; 35(18):2463-2472. PubMed ID: 28341111
[TBL] [Abstract][Full Text] [Related]
4. Natural infections with different Plasmodium species induce antibodies reactive to a chimeric Plasmodium vivax recombinant protein.
McCaffery JN; Singh B; Nace D; Moreno A; Udhayakumar V; Rogier E
Malar J; 2021 Feb; 20(1):86. PubMed ID: 33579292
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).
Rosa DS; Iwai LK; Tzelepis F; Bargieri DY; Medeiros MA; Soares IS; Sidney J; Sette A; Kalil J; Mello LE; Cunha-Neto E; Rodrigues MM
Microbes Infect; 2006 Jul; 8(8):2130-7. PubMed ID: 16797207
[TBL] [Abstract][Full Text] [Related]
6. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
7. Protective Immunity in Mice Immunized With
Dobrescu I; de Camargo TM; Gimenez AM; Murillo O; Amorim KNDS; Marinho CRF; Soares IS; Boscardin SB; Bargieri DY
Front Immunol; 2020; 11():28. PubMed ID: 32153555
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
[TBL] [Abstract][Full Text] [Related]
9. A Multi-Stage
McCaffery JN; Fonseca JA; Singh B; Cabrera-Mora M; Bohannon C; Jacob J; Arévalo-Herrera M; Moreno A
Front Cell Infect Microbiol; 2019; 9():135. PubMed ID: 31119106
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.
Ferreira AR; Singh B; Cabrera-Mora M; Magri De Souza AC; Queiroz Marques MT; Porto LC; Santos F; Banic DM; Calvo-Calle JM; Oliveira-Ferreira J; Moreno A; Lima-Junior JC
PLoS One; 2014; 9(8):e105828. PubMed ID: 25148251
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.
Sheikh IH; Kaushal DC; Chandra D; Kaushal NA
Acta Trop; 2016 Oct; 162():66-74. PubMed ID: 27311385
[TBL] [Abstract][Full Text] [Related]
12. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; Espíndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted non-glycosylated polypeptide from Pichia pastoris.
Soares IS; Rodrigues MM
Parasitology; 2002 Mar; 124(Pt 3):237-46. PubMed ID: 11922426
[TBL] [Abstract][Full Text] [Related]
14. A Chimeric Plasmodium vivax Merozoite Surface Protein Antibody Recognizes and Blocks Erythrocytic P. cynomolgi Berok Merozoites
Shen FH; Ong JJY; Sun YF; Lei Y; Chu RL; Kassegne K; Fu HT; Jin C; Han ET; Russell B; Han JH; Cheng Y
Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33199351
[TBL] [Abstract][Full Text] [Related]
15. The use of a chimeric antigen for Plasmodium falciparum and P. vivax seroprevalence estimates from community surveys in Ethiopia and Costa Rica.
McCaffery JN; Singh B; Nace D; Assefa A; Hwang J; Plucinski M; Calvo N; Moreno A; Udhayakumar V; Rogier E
PLoS One; 2022; 17(5):e0263485. PubMed ID: 35613090
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity of Merozoite surface protein 1-42 (MSP1-42) fragment of Plasmodium vivax from Indonesian isolates: Rationale implementation of candidate MSP1 vaccine.
Murhandarwati EEH; Herningtyas EH; Puspawati P; Mau F; Chen SB; Shen HM; Chen JH
Infect Genet Evol; 2020 Nov; 85():104573. PubMed ID: 32987191
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors.
Cunha MG; Rodrigues MM; Soares IS
Vaccine; 2001 Nov; 20(3-4):385-96. PubMed ID: 11672901
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
Soares IS; Oliveira SG; Souza JM; Rodrigues MM
Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
Fonseca JA; McCaffery JN; Caceres J; Kashentseva E; Singh B; Dmitriev IP; Curiel DT; Moreno A
Vaccine; 2018 May; 36(20):2799-2808. PubMed ID: 29657070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
